British American Tobacco p.l.c. provides tobacco and nicotine products to consumers worldwide. It offers vapour products, tobacco heating products, and modern oral products; combustible products; and traditional oral products, such as Swedish-style snus and American moist snuff. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.
IPO Year: 1998
Exchange: NYSE
Website: bat.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/3/2024 | $33.00 | Overweight → Underweight | Morgan Stanley |
| 1/23/2024 | Neutral | UBS | |
| 11/1/2023 | $38.00 | Overweight | Morgan Stanley |
| 9/25/2023 | Buy | Citigroup | |
| 9/1/2023 | Buy → Hold | Argus | |
| 3/13/2023 | Overweight → Neutral | JP Morgan | |
| 11/2/2022 | Buy → Neutral | Goldman | |
| 3/24/2022 | Neutral → Overweight | JP Morgan |
6-K - British American Tobacco p.l.c. (0001303523) (Filer)
6-K - British American Tobacco p.l.c. (0001303523) (Filer)
6-K - British American Tobacco p.l.c. (0001303523) (Filer)
6-K - British American Tobacco p.l.c. (0001303523) (Filer)
6-K - British American Tobacco p.l.c. (0001303523) (Filer)
6-K - British American Tobacco p.l.c. (0001303523) (Filer)
6-K - British American Tobacco p.l.c. (0001303523) (Filer)
6-K - British American Tobacco p.l.c. (0001303523) (Filer)
6-K - British American Tobacco p.l.c. (0001303523) (Filer)
6-K - British American Tobacco p.l.c. (0001303523) (Filer)
3 - British American Tobacco p.l.c. (0001303523) (Reporting)
As of July 25, 2024, three stocks in the consumer staples sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices go down. When compared to a stock’s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the RSI is above 70, according to Benzinga Pro. Here's the latest list of major overbought players in this sector. Unilever plc (NYSE:UL) On July 25, Unilever reported quarterly adjusted earnings of $1
After an extensive scientific review, the Food and Drug Administration (FDA) issued marketing granted orders to R.J. Reynolds Vapor Company, a subsidiary of British American Tobacco P.L.C. (NYSE:BTI), for the Vuse Alto Power Unit and six Vuse Alto tobacco-flavored pods, which are sealed, pre-filled, and non-refillable. While the FDA is authorizing the marketing of these tobacco products in the U.S., it does not mean these tobacco products are safe nor are they “FDA approved.” Additionally, this action is not an authorization or indication of appropriateness to market these products as modified risk tobacco products. FDA evaluates premarket tobacco product application (PMTAs) based o
- Bloomberg
On July 10, Zuanic & Associates hosted a panel discussion focusing on the European cannabis market, featuring Benna Goldenberg, CEO of Organigram Holdings (NASDAQ:OGI), and Finn Age Hansel, CEO of Sanity Group. Senior analyst Pablo Zuanic led the discussion, which centered on the companies' strategies for expanding in Germany and the broader European market. Organigram's Strategic Move In Germany Organigram has been actively expanding its presence in the international markets, with a particular focus on Germany. And, according to CEO Benna Goldenberg, the company's partnership with Sanity Group is a key element in this strategy. The collaboration is bolstered by British American Tobacco (
https://www.statnews.com/2024/06/28/vape-makers-fda-supreme-court-chevron-doctrine/WASHINGTON — Vape manufacturers are taking a victory lap over a Supreme Court decision that could dramatically weaken the Food and Drug Administration's power to regulate tobacco and nicotine products as regulators see fit.The court on Friday overturned a judicial rule, known as the Chevron doctrine, which instructed courts to defer to regulators on certain legal issues. Vape manufacturers see the decision as a powerful weapon in their fight against the FDA's efforts to ban the majority of vapes lining store shelves.The FDA has argued that its decision to ban more than 1 million vapes is in line with a 2009 la
The U.S. Supreme Court has overturned a 40-year-old decision that gave the executive branch the power to rule on laws passed by Congress that were unclear. The decision, known as the Chevron doctrine, stems from a unanimous Supreme Court case involving the energy company in an argument over the Clean Air Act that upheld an action by the Environmental Protection Agency under then-President Ronald Reagan. Since then, the Chevron decision has required judges to defer to agencies' reasonable interpretations of congressional statutes. Friday’s 6-3 ruling to overturn the doctrine allows judges to decide on laws that are considered ambiguous. The 1984 ruling has long been in the crosshairs
British American Tobacco PLC (NYSE:BTI) stock is turning heads on Wall Street with a classic bullish signal approaching: the Golden Cross. This technical pattern, where the 50-day simple moving average (SMA) rockets past the 200-day SMA, often heralds a strong upward trend. But that’s just the beginning of the company’s bullish bonanza. Technicals Indicate Strong Bullish Momentum The Golden Cross is just one of several technical metrics supporting a bullish stance on British American Tobacco. The stock is currently trading at $32.13, well above its 5, 20, and 50-day exponential moving averages (EMAs). This positioning indicates a strong bullish trend, reinforced by slight buyin
https://www.fda.gov/news-events/press-announcements/fda-authorizes-marketing-four-menthol-flavored-e-cigarette-products-after-extensive-scientific
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises British American Tobacco p.l.c (NYSE:BTI) investors that a lawsuit was filed on behalf of investors that purchased BTI securities between February 9, 2023 and December 6, 2023, inclusive (the "Class Period"). Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 844-767-8529 or email: [email protected], to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors' options for pursuing cla
Provides Update on Majority Voting Policy Process LOUISVILLE, Colo., Sept. 13, 2023 /PRNewswire/ - (TSX:CWEB) (OTCQX:CWBHF) Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company") is pleased to announce the appointment of William (Bill) Morachnick who has joined the Company as its Chief Executive Officer. Mr. Morachnick has also been appointed to the Company's Board of Directors as a non-independent director. He replaces CEO Jacques Tortoroli who has elected to resign from his roles at Charlotte's Web. CWEB) (OTCQX:CWBHF):. The World's Most Trusted Hemp Extract and Official CBD of Major League Baseball (MLB). (C
SAN DIEGO, Calif., June 22, 2022 /PRNewswire/ - Greenbutts, LLC (the "Company" or "Greenbutts") is pleased to announce the appointment of Luis Sanches as the Company's Chief Strategy Officer effective immediately. Luis is a Senior Corporate Executive with more than 30 years of international, cross functional and cross-cultural experience responsible for managing business teams, supporting growth, and leading transformations across multiple geographies such as Australasia, North and South America, and Europe. He was previously the Senior Vice President of R&D for Reynolds Ameri
COLMAR, Pa., Nov. 02, 2021 (GLOBE NEWSWIRE) -- Dorman Products, Inc. (the "Company") (NASDAQ:DORM) today announced that J. Darrell Thomas has been appointed as an independent director to the Company's Board of Directors, effective October 30, 2021. Mr. Thomas' appointment expands the Board to nine directors, seven of whom are independent directors. Mr. Thomas will be a member of the Company's Audit, Compensation and Corporate Governance and Nominating committees. Mr. Thomas currently serves as Vice President and Treasurer for Harley-Davidson, Inc. (NYSE:HOG), which he joined in June 2010. During his tenure at Harley-Davidson, he also has served in several other senior finance positions, i
LOUISVILLE, Colo., May 8, 2024 /PRNewswire/ - (TSX:CWEB) (OTCQX:CWBHF), Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), the market leader in full-spectrum hemp extract wellness products, today reported financial results for the first quarter ended March 31, 2024. "The first quarter of 2024 started slowly in terms of sales volume. This is being addressed with solid progress in our 'True North' turnaround initiatives," said Bill Morachnick, Chief Executive Officer of Charlotte's Web. "For example, our legacy e-commerce platform limits our ability to be agile
Encouraging CBD regulatory progress in CongressNet revenue of $16.0M vs. $18.9M YoYCash increased to $61.7M LOUISVILLE, Colo., Aug. 10, 2023 /PRNewswire/ - (TSX:CWEB) (OTCQX:CWBHF), Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), the market leader in full spectrum hemp extract wellness products, today reported financial results for the second quarter ended June 30, 2023. Regulatory Update During the second quarter, the U.S. Food and Drug Administration ("FDA") committed to "work at speed" with Congress to resolve a regulatory pathway for hemp-derived CBD.
Net cash of $61MNet revenue of $17M decreased 12.1% YoY14% YoY reduction in operating expenses LOUISVILLE, Colo., May 12, 2023 /PRNewswire/ - (TSX:CWEB) (OTCQX:CWBHF), Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), the market leader in full spectrum hemp extract wellness products, today reported financial results for the first quarter ended March 31, 2023. "In the first quarter, we maintained prudent cost controls to balance softness in the CBD category due to the unregulated environment. We successfully reduced operating expenses by 14% on a year-over-ye
28% reduction in 12-month operating expenses Net cash of $67M at December 31, 2022 LOUISVILLE, Colo., March 23, 2023 /PRNewswire/ - (TSX:CWEB) (OTCQX:CWBHF), Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), the market leader in full spectrum hemp extract wellness products, today reported financial results for the fourth quarter and year ended December 31, 2022. All amounts are expressed in United States dollars unless otherwise indicated. Percentage changes are calculated to the nearest thousand dollars. "In the fourth quarter, Charlotte's Web cemented an a
LOUISVILLE, Colo., May 8, 2024 /PRNewswire/ - (TSX:CWEB) (OTCQX:CWBHF), Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), the market leader in full-spectrum hemp extract wellness products, today reported financial results for the first quarter ended March 31, 2024. "The first quarter of 2024 started slowly in terms of sales volume. This is being addressed with solid progress in our 'True North' turnaround initiatives," said Bill Morachnick, Chief Executive Officer of Charlotte's Web. "For example, our legacy e-commerce platform limits our ability to be agile
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises British American Tobacco p.l.c (NYSE:BTI) investors that a lawsuit was filed on behalf of investors that purchased BTI securities between February 9, 2023 and December 6, 2023, inclusive (the "Class Period"). Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 844-767-8529 or email: [email protected], to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors' options for pursuing cla
Organigram and BAT deepen partnership through C$124.6 million investment with 38.7 million shares to be issued over three tranches Organigram to use C$83.1 million of the investment to create "Jupiter," a strategic investment pool designed to expand Organigram's geographic footprint and capitalize on emerging growth opportunities C$41.5 million of the investment will be used for general corporate purposes Investment enhances strategic Product Development Collaboration between BAT and Organigram, which focuses on cutting-edge R&D and product innovation BAT to increase voting Common Share ownership position to 30% and overall equity interest to 45% (including non-voting Class A P
Provides Update on Majority Voting Policy Process LOUISVILLE, Colo., Sept. 13, 2023 /PRNewswire/ - (TSX:CWEB) (OTCQX:CWBHF) Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company") is pleased to announce the appointment of William (Bill) Morachnick who has joined the Company as its Chief Executive Officer. Mr. Morachnick has also been appointed to the Company's Board of Directors as a non-independent director. He replaces CEO Jacques Tortoroli who has elected to resign from his roles at Charlotte's Web. CWEB) (OTCQX:CWBHF):. The World's Most Trusted Hemp Extract and Official CBD of Major League Baseball (MLB). (C
Encouraging CBD regulatory progress in CongressNet revenue of $16.0M vs. $18.9M YoYCash increased to $61.7M LOUISVILLE, Colo., Aug. 10, 2023 /PRNewswire/ - (TSX:CWEB) (OTCQX:CWBHF), Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), the market leader in full spectrum hemp extract wellness products, today reported financial results for the second quarter ended June 30, 2023. Regulatory Update During the second quarter, the U.S. Food and Drug Administration ("FDA") committed to "work at speed" with Congress to resolve a regulatory pathway for hemp-derived CBD.
Net cash of $61MNet revenue of $17M decreased 12.1% YoY14% YoY reduction in operating expenses LOUISVILLE, Colo., May 12, 2023 /PRNewswire/ - (TSX:CWEB) (OTCQX:CWBHF), Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), the market leader in full spectrum hemp extract wellness products, today reported financial results for the first quarter ended March 31, 2023. "In the first quarter, we maintained prudent cost controls to balance softness in the CBD category due to the unregulated environment. We successfully reduced operating expenses by 14% on a year-over-ye
BAT acquires 20% stake for US$10 million, with Charlotte's Web and AJNA each owning 40% Renowned neurologist Dr. Orrin Devinsky, Chief Medical Advisor for AJNA, to lead the project DENVER, April 6, 2023 /PRNewswire/ - (TSX:CWEB) (OTCQX:CWBHF), Charlotte's Web Holdings, Inc. ("Charlotte's Web," "CW" or the "Company"), the market leader in full-spectrum hemp extract wellness products, today announced it has formed a joint venture (the "JV") with AJNA BioSciences PBC ("AJNA"), a botanical drug development company focused on mental health and neurological disorders , and a subsidiary of British American Tobacco PLC (NYSE:BTI) ("BAT"), which is contributing US$10 million as the JV's initial inve
28% reduction in 12-month operating expenses Net cash of $67M at December 31, 2022 LOUISVILLE, Colo., March 23, 2023 /PRNewswire/ - (TSX:CWEB) (OTCQX:CWBHF), Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), the market leader in full spectrum hemp extract wellness products, today reported financial results for the fourth quarter and year ended December 31, 2022. All amounts are expressed in United States dollars unless otherwise indicated. Percentage changes are calculated to the nearest thousand dollars. "In the fourth quarter, Charlotte's Web cemented an a
Investment Will Help Drive Growth and Deepen R&D DENVER, Nov. 15, 2022 /PRNewswire/ - (TSX:CWEB) (OTCQX:CWBHF) Charlotte's Web Holdings, Inc. ("Charlotte's Web," or the "Company") the market leader in hemp-derived cannabidiol ("CBD") wellness products, today announced a US$56.8 million investment (the "Investment") from a subsidiary of BAT (LSE: BATS) and (NYSE:BTI), which provides the Company with incremental capital to fund growth initiatives, including the Company's expanding portfolio of botanical wellness products. CWEB) (OTCQX:CWBHF) announces strategic investment from BAT (NYSE:BTI) (CNW Group/Charlotte's Web Holdings
SAN DIEGO, Calif., June 22, 2022 /PRNewswire/ - Greenbutts, LLC (the "Company" or "Greenbutts") is pleased to announce the appointment of Luis Sanches as the Company's Chief Strategy Officer effective immediately. Luis is a Senior Corporate Executive with more than 30 years of international, cross functional and cross-cultural experience responsible for managing business teams, supporting growth, and leading transformations across multiple geographies such as Australasia, North and South America, and Europe. He was previously the Senior Vice President of R&D for Reynolds Ameri
SC 13G/A - British American Tobacco p.l.c. (0001303523) (Subject)
SC 13G/A - British American Tobacco p.l.c. (0001303523) (Subject)
SC 13G/A - British American Tobacco p.l.c. (0001303523) (Subject)
SC 13G/A - British American Tobacco p.l.c. (0001303523) (Subject)
SC 13G - British American Tobacco p.l.c. (0001303523) (Subject)
SC 13G - British American Tobacco p.l.c. (0001303523) (Subject)
SC 13G/A - British American Tobacco p.l.c. (0001303523) (Subject)
SC 13G/A - British American Tobacco p.l.c. (0001303523) (Subject)
SC 13G/A - British American Tobacco p.l.c. (0001303523) (Subject)
SC 13G - British American Tobacco p.l.c. (0001303523) (Subject)
Morgan Stanley downgraded British American Tobacco from Overweight to Underweight and set a new price target of $33.00
UBS resumed coverage of British American Tobacco with a rating of Neutral
Morgan Stanley initiated coverage of British American Tobacco with a rating of Overweight and set a new price target of $38.00
Citigroup resumed coverage of British American Tobacco with a rating of Buy
Argus downgraded British American Tobacco from Buy to Hold
JP Morgan downgraded British American Tobacco from Overweight to Neutral
Goldman downgraded British American Tobacco from Buy to Neutral
JP Morgan upgraded British American Tobacco from Neutral to Overweight
JP Morgan downgraded British American Tobacco from Overweight to Neutral
Jefferies upgraded British American Tobacco from Hold to Buy